Practice Summary
David joined Bozicevic, Field & Francis in 2004 as a technical advisor in the areas of stem cell biology, cell-based therapies, microbiology, molecular biology, immunology and biotechnology. While contributing his technical expertise to the firm, David rapidly gained experience in patent prosecution practice and intellectual property portfolio analyses. David passed the Patent Bar exam early in 2005 to become a registered Patent Agent. His practice includes patent application drafting and prosecution.

David received a Bachelor of Science degree in Microbiology in 1991 and a Masters of Science degree in Microbiology in 1993 from the University of Montana. In 1997 while attending Vanderbilt University he was awarded the Sidney P. Colowick Award in Recognition of Research Achievements in the Department of Microbiology and Immunology. After receiving a Ph.D. in Microbiology and Immunology from Vanderbilt in 1998, he continued research as a postdoctoral fellow in the laboratory of Dr. Irving Weissman at Stanford University School of Medicine investigating the early stages of mammalian lymphocyte development in bone marrow. Prior to his research at Stanford, David was a postdoctoral fellow at the Howard Hughes Medical Institute of Vanderbilt University.

In the course of his education and research David has co-authored numerous articles which have been published in industry-standard journals such as Nature, Gene, Molecular and Cellular Biology, Proceedings of the National Academy of Science, The Journal of Biological Chemistry and The European Journal of Immunology. Notable topics include analysis of motility as a virulence factor in the bacterial erythrocyte pathogen Bartonella bacilliformis, the post-translational modifications that control the regulation of the signal transduction pathway, and the role of cytokines and the cell surface expression of their receptors in governing cell-fate decisions in early lymphocyte progenitors.

Following his graduate work and postdoctoral research, David joined Cellerant Therapeutics, Inc. in 2002 as the first staff scientist, where he set up the research labs and worked closely with members of the management team to secure its first round of funding. In July 2003 he was awarded a grant for research on validation of a novel parallel hematopoietic cell sorter. During his graduate studies at Vanderbilt University, David was supported by the Cancer and Immunobiology training grant from the National Institutes of Health. During his post-doctoral studies, David was awarded post-doctoral fellowship grants from the American Cancer Society and the Cancer Research Institute.

David is registered to practice before the U.S. Patent and Trademark Office.